Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (AMR2)Product type:GuidanceProgramme:Antimicrobial resistance guidancePublished: 17 August 2022
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections (AMR1)Product type:GuidanceProgramme:Antimicrobial resistance guidancePublished: 17 August 2022